• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.一项前瞻性乳腺癌幸存者研究中淋巴水肿的危险因素:路径研究
Arch Surg. 2010 Nov;145(11):1055-63. doi: 10.1001/archsurg.2010.231.
2
Risky business: Identifying risk factors associated with lymphedema after breast cancer: Comment on "Risk factors for lymphedema in a prospective breast cancer survivorship study".风险业务:识别与乳腺癌后淋巴水肿相关的风险因素:对“一项前瞻性乳腺癌幸存者研究中淋巴水肿的风险因素”的评论
Arch Surg. 2010 Nov;145(11):1063-4. doi: 10.1001/archsurg.2010.1063.
3
Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years.乳腺癌相关淋巴水肿的危险因素、早期康复及管理的影响:5 年以上乳腺癌幸存者的回顾性研究。
BMC Womens Health. 2024 Apr 6;24(1):226. doi: 10.1186/s12905-024-03062-7.
4
Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial.女性乳腺癌相关淋巴水肿风险患者举重:一项随机试验。
JAMA. 2010 Dec 22;304(24):2699-705. doi: 10.1001/jama.2010.1837. Epub 2010 Dec 8.
5
Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.伊朗南部设拉子地区乳腺癌女性淋巴水肿的相关因素:一项病例对照研究
Asian Pac J Cancer Prev. 2016;17(S3):81-6. doi: 10.7314/apjcp.2016.17.s3.81.
6
The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.术后乳腺癌幸存者相关淋巴水肿的发生率和风险因素:一项为期 2 年的随访前瞻性队列研究。
Breast Cancer. 2018 May;25(3):309-314. doi: 10.1007/s12282-018-0830-3. Epub 2018 Feb 3.
7
Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting.在一个大型综合医疗服务环境中,临床医生对乳腺癌相关淋巴水肿的认识和了解。
Breast Cancer Res Treat. 2012 Feb;131(3):1029-38. doi: 10.1007/s10549-011-1829-z. Epub 2011 Oct 29.
8
Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis.诊断后 10 年乳腺癌幸存者的手臂淋巴水肿。
Acta Oncol. 2010;49(2):166-73. doi: 10.3109/02841860903483676.
9
Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.应用生物电阻抗分析检测乳腺癌幸存者淋巴水肿:一项前瞻性横断面研究。
BMC Cancer. 2019 Jul 8;19(1):669. doi: 10.1186/s12885-019-5840-9.
10
Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.女性乳腺癌幸存者自我报告的手臂淋巴水肿的危险因素:一项前瞻性队列研究。
Breast Cancer Res. 2014 Aug 22;16(4):414. doi: 10.1186/s13058-014-0414-x.

引用本文的文献

1
The Role of Axillary Lymph Node Dissection in Breast Cancer Patients With Residual Nodal Disease After Receiving Neoadjuvant Chemotherapy.腋窝淋巴结清扫术在接受新辅助化疗后仍有残留淋巴结疾病的乳腺癌患者中的作用。
Breast Cancer (Auckl). 2025 Aug 10;19:11782234251352996. doi: 10.1177/11782234251352996. eCollection 2025.
2
Development and validation of a predictive nomogram for postoperative upper limb lymphedema in breast cancer patients: a retrospective cohort study.乳腺癌患者术后上肢淋巴水肿预测列线图的开发与验证:一项回顾性队列研究
Sci Rep. 2025 Jul 9;15(1):24609. doi: 10.1038/s41598-025-10461-9.
3
Disparities in Breast Cancer-related Lymphedema: A Systematic Review of Inequities and Barriers in Care.乳腺癌相关淋巴水肿的差异:对护理中的不公平现象和障碍的系统评价
Plast Reconstr Surg Glob Open. 2025 Jul 1;13(7):e6935. doi: 10.1097/GOX.0000000000006935. eCollection 2025 Jul.
4
Immediate lymphatic reconstruction for breast cancer-related lymphedema prevention: A systematic review.乳腺癌相关淋巴水肿预防的即时淋巴重建:一项系统综述。
JPRAS Open. 2025 Apr 4;44:448-462. doi: 10.1016/j.jpra.2025.03.021. eCollection 2025 Jun.
5
Predictors of the Efficacy of Lymphedema Decongestive Therapy.淋巴水肿减压治疗疗效的预测因素
Medicina (Kaunas). 2025 Jan 27;61(2):231. doi: 10.3390/medicina61020231.
6
The influence of non-cancer-related risk factors on the development of cancer-related lymphedema: a rapid review.非癌症相关风险因素对癌症相关淋巴水肿发展的影响:快速综述。
Med Oncol. 2024 Oct 14;41(11):274. doi: 10.1007/s12032-024-02474-7.
7
Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.乳腺癌相关淋巴水肿预防的综合策略:来自多方面项目的见解。
Front Oncol. 2024 Jul 16;14:1418610. doi: 10.3389/fonc.2024.1418610. eCollection 2024.
8
The role of breast cancer-related arm lymphedema in physical functioning and physical activity participation among long-term African American breast cancer survivors.乳腺癌相关上肢淋巴水肿对长期非裔美国乳腺癌幸存者身体功能和身体活动参与的影响。
Support Care Cancer. 2024 Jun 20;32(7):446. doi: 10.1007/s00520-024-08648-3.
9
Bibliometric analysis of breast cancer-related lymphedema research trends over the last 2 decades.过去20年乳腺癌相关淋巴水肿研究趋势的文献计量分析。
Front Oncol. 2024 Feb 20;14:1360899. doi: 10.3389/fonc.2024.1360899. eCollection 2024.
10
Demystifying vascularized lymph node transfers and lymphatico-venous anastomoses.揭秘带血管蒂淋巴结转移术及淋巴管-静脉吻合术
Ann Transl Med. 2024 Feb 1;12(1):8. doi: 10.21037/atm-23-132. Epub 2023 Jul 10.

本文引用的文献

1
Weight lifting in women with breast-cancer-related lymphedema.乳腺癌相关淋巴水肿女性的举重运动
N Engl J Med. 2009 Aug 13;361(7):664-73. doi: 10.1056/NEJMoa0810118.
2
A contemporary, population-based study of lymphedema risk factors in older women with breast cancer.一项针对老年乳腺癌女性淋巴水肿风险因素的当代人群研究。
Ann Surg Oncol. 2009 Apr;16(4):979-88. doi: 10.1245/s10434-009-0347-2. Epub 2009 Feb 5.
3
Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study.乳腺癌幸存者的淋巴水肿与生活质量:爱荷华州女性健康研究
J Clin Oncol. 2008 Dec 10;26(35):5689-96. doi: 10.1200/JCO.2008.16.4731. Epub 2008 Nov 10.
4
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.前哨淋巴结活检或腋窝清扫术后5年乳腺癌女性患者淋巴水肿的患病率:客观测量
J Clin Oncol. 2008 Nov 10;26(32):5213-9. doi: 10.1200/JCO.2008.16.3725. Epub 2008 Oct 6.
5
Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.前哨淋巴结活检和腋窝完全清扫患者的肩臂发病率——来自一项前瞻性随机试验的数据
Eur J Surg Oncol. 2009 Jul;35(7):696-701. doi: 10.1016/j.ejso.2008.06.013. Epub 2008 Oct 5.
6
Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.乳腺癌后的淋巴水肿:发病率、危险因素及对上身功能的影响。
J Clin Oncol. 2008 Jul 20;26(21):3536-42. doi: 10.1200/JCO.2007.14.4899.
7
The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California.途径研究:北加利福尼亚凯撒医疗集团内乳腺癌幸存者的前瞻性研究。
Cancer Causes Control. 2008 Dec;19(10):1065-76. doi: 10.1007/s10552-008-9170-5. Epub 2008 May 14.
8
Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.前哨淋巴结活检或腋窝淋巴结清扫术后的手臂并发症:丹麦乳腺癌协作组的一项研究
Breast. 2008 Apr;17(2):138-47. doi: 10.1016/j.breast.2007.08.006. Epub 2007 Oct 24.
9
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.临床腋窝淋巴结阴性乳腺癌患者前哨淋巴结切除与传统腋窝淋巴结清扫的技术结果:NSABP B - 32随机III期试验的结果
Lancet Oncol. 2007 Oct;8(10):881-8. doi: 10.1016/S1470-2045(07)70278-4.
10
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.在美国外科医师学会肿瘤学组Z0011试验中,前哨淋巴结清扫术(SLND)联合腋窝淋巴结清扫术与单纯SLND相比的手术并发症。
J Clin Oncol. 2007 Aug 20;25(24):3657-63. doi: 10.1200/JCO.2006.07.4062. Epub 2007 May 7.

一项前瞻性乳腺癌幸存者研究中淋巴水肿的危险因素:路径研究

Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.

作者信息

Kwan Marilyn L, Darbinian Jeanne, Schmitz Kathryn H, Citron Rebecca, Partee Paula, Kutner Susan E, Kushi Lawrence H

机构信息

Kaiser Permanente Northern California, Oakland, 94612, USA.

出版信息

Arch Surg. 2010 Nov;145(11):1055-63. doi: 10.1001/archsurg.2010.231.

DOI:10.1001/archsurg.2010.231
PMID:21079093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2997775/
Abstract

OBJECTIVE

To determine the incidence of breast cancer-related lymphedema (BCRL) during the early survivorship period as well as demographic, lifestyle, and clinical factors associated with BCRL development.

DESIGN

The Pathways Study, a prospective cohort study of breast cancer survivors with a mean follow-up time of 20.9 months.

SETTING

Kaiser Permanente Northern California medical care program.

PARTICIPANTS

We studied 997 women diagnosed from January 9, 2006, through October 15, 2007, with primary invasive breast cancer and who were at least 21 years of age at diagnosis, had no history of any cancer, and spoke English, Spanish, Cantonese, or Mandarin.

MAIN OUTCOME MEASURE

Clinical indication for BCRL as determined from outpatient or hospitalization diagnostic codes, outpatient procedural codes, and durable medical equipment orders.

RESULTS

A clinical indication for BCRL was found in 133 women (13.3%), with a mean time to diagnosis of 8.3 months (range, 0.7-27.3 months). Being African American (hazard ratio, 1.93; 95% confidence interval, 1.00-3.72) or more educated (P for trend = .03) was associated with an increased risk of BCRL. Removal of at least 1 lymph node (hazard ratio, 1.04; 95% confidence interval, 1.02-1.07) was associated with an increased risk, yet no significant association was observed for type of lymph node surgery. Being obese at breast cancer diagnosis was suggestive of an elevated risk (hazard ratio, 1.43; 95% confidence interval, 0.88-2.31).

CONCLUSIONS

In a large cohort study, BCRL occurs among a substantial proportion of early breast cancer survivors. Our findings agree with those of previous studies on the increased risk of BCRL with removal of lymph nodes and being obese, but they point to a differential risk according to race or ethnicity.

摘要

目的

确定乳腺癌相关淋巴水肿(BCRL)在早期生存阶段的发病率,以及与BCRL发生相关的人口统计学、生活方式和临床因素。

设计

路径研究,一项对乳腺癌幸存者的前瞻性队列研究,平均随访时间为20.9个月。

地点

北加利福尼亚凯撒医疗保健项目。

参与者

我们研究了997名女性,她们于2006年1月9日至2007年10月15日被诊断为原发性浸润性乳腺癌,诊断时年龄至少21岁,无任何癌症病史,且说英语、西班牙语、粤语或普通话。

主要观察指标

根据门诊或住院诊断代码、门诊手术代码和耐用医疗设备订单确定的BCRL临床指征。

结果

133名女性(13.3%)有BCRL临床指征,诊断的平均时间为8.3个月(范围为0.7 - 27.3个月)。非裔美国人(风险比,1.93;95%置信区间,1.00 - 3.72)或受教育程度较高(趋势P值 = 0.03)与BCRL风险增加相关。切除至少1个淋巴结(风险比,1.04;95%置信区间,1.02 - 1.07)与风险增加相关,但未观察到淋巴结手术类型与BCRL有显著关联。乳腺癌诊断时肥胖提示风险升高(风险比,1.43;95%置信区间,0.88 - 2.31)。

结论

在一项大型队列研究中,BCRL在相当比例的早期乳腺癌幸存者中发生。我们的研究结果与先前关于切除淋巴结和肥胖会增加BCRL风险的研究一致,但指出了种族或民族之间的风险差异。